ClinicalTrials.gg
RecruitingNCT05545176Updated Feb 25, 2026

The Validation and Development of Termination-of-Resuscitation (TOR) Rules in OHCA Patients in Asia Countries

An observational study in Out-Of-Hospital Cardiac Arrest, sponsored by National Taiwan University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-25.

Sponsored by National Taiwan University Hospital · Observational

How we know

From the registry’s dates

  • Started Jan 2007; still recruiting 19 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
140,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Out-of-Hospital Cardiac Arrest by National Taiwan University Hospital — 6 open to participants now, 7 under way, none of them phase 3. Out-of-Hospital Cardiac Arrest · National Taiwan University Hospital.

Started
2007
the only one that year
Observational
7 of 15
4 open now
Registered
7th of 15
by date

Among the 15 studies in Out-of-Hospital Cardiac Arrest by National Taiwan University Hospital, this one is the only one that started in 2007, is one of 7 observational ones, and was the 7th registered.

Out-of-Hospital Cardiac Arrest

314 studies on the registry are indexed under Out-of-Hospital Cardiac Arrest; 93 are open to participants now.

Browse Out-of-Hospital Cardiac Arrest studies →

Open to participants now

6 of the 15 studies in Out-of-Hospital Cardiac Arrest by National Taiwan University Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 66 Out-of-Hospital Cardiac Arrest studies recruiting now, 46 (70%) set no upper age limit and 13 (20%) stop at 75 or younger; 8 take children under 18; 7 take healthy volunteers.

This study: 18 Years and older · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Out-of-Hospital Cardiac Arrest by National Taiwan University Hospital, or all of them as a file.
02

Study summary

Objectives/Hypotheses

  1. Prehospital termination-of-resuscitation (TOR) rules were developed in North American and European sites. Whether they remained valid in different geographic, ethnic, and cultural background areas is still under debate.
  2. Differences in characteristics of out-of-hospital cardiac arrests (OHCAs) and configurations of emergency medical service (EMS) between the Western and Asian countries, including relatively lower rate of presenting shockable rhythm (i.e. ventricular fibrillation / ventricular tachycardia; VF/VT), lower rates of bystander CPR, less advanced life support (ALS) implementation, and less public access defibrillators, might create potential threats to the prediction accuracy of TOR rules.
  3. We aim to conduct a study to validate the performance of ever published TOR rules in Asian OHCA population, including non-traumatic, traumatic, and pediatric OHCA patients. Furthermore, assess the possible variables that may impact the performance of TOR rules.
  4. We also aim to develop new TOR rules based on PAROS registry for Asia population, focusing on non-traumatic, traumatic, and pediatric OHCA patients, respectively.
03

Conditions studied

  • Out-Of-Hospital Cardiac Arrest

Keywords

  • Out-Of-Hospital Cardiac Arrest
  • OHCA
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

The study population included adults, OHCA patients since1 January 2007, identified from the PAROS registry. The PAROS data encompass 13 countries. The exclusion criteria include: (1) age \<18 years, (2) non-EMS transport to the emergency department, (3) obvious signs of death (e.g. decapitation, rigor mortis, lividity, and decapitation) or having do-not-resuscitate (DNR) orders, and (4) missing data despite meeting the inclusion criteria.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • out of hospital cardiac arrest (OHCA) patients

Exclusion criteria

Exclusion Criteria:

  • age \<18 years
  • non-EMS transport to the emergency department
  • obvious signs of death (e.g. decapitation, rigor mortis, lividity, and decapitation) or having do-not-resuscitate (DNR) orders
  • missing data despite meeting the inclusion criteria.
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
140,000 participants (estimated)
Target follow-up
20 Years
Patient registry
Yes

Groups and cohorts

  • out of hospital cardiac arrest patients in Asia countries

    Other: termination of resuscitation rules

Interventions

  • Othertermination of resuscitation rules

    Use retrospective data to analyze the accuracy termination of resuscitation rules and further develope a termination of resuscitation rule.

06

What researchers measure

Primary outcomes

  1. survival to hospital discharge

    survival to 30-day hospitalisation

    Time frame: survival to 30-day hospitalisation

Secondary outcomes

  1. Cerebral Performance Categories Scale (CPC)

    CPC Scale 1\~5, minimum value: 1; maximum value:5; lower score means greater outcome

    Time frame: CPC within 30-day hospitalisation

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Clinical study report

Time frame: 30 years

Access criteria: PAROS study members

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2007 (actual). Primary completion is estimated for Jun 2032, 305 months after the start.

Of 69 non-industry observational studies under Out-of-Hospital Cardiac Arrest, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 75. This study's planned 305 months is above that.

Counting every sponsor, half of 69 studies reached it within 46 months; a quarter within 20 and three quarters within 75.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 14, 2022
First posted
Sep 19, 2022
StartActual
Jan 1, 2007
Primary completionEst.
Jun 1, 2032
CompletionEst.
Dec 31, 2032
Last update
Feb 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05545176
Collaborators
Singapore Clinical Research Institute
Responsible party
Sponsor
First posted
Sep 19, 2022
Start date
Jan 1, 2007
Primary completion
Jun 1, 2032 (estimated)
Completion
Dec 31, 2032 (estimated)
Last update
Feb 25, 2026

Study contacts

Shu-Hsien Hsu, MPH
Contact
pedroe929@gmail.com
Shu-Hsien Hsu, MPH
principal investigator · National Taiwan University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion